HOT PRODUCT | LOW STOCK
HD Labs Tirsema 44mg™
HD Labs Tirsema 44mg™
✨ Premium quality you can trust
🧬 Science inspired performance essentials
🚚 Fast, secure nationwide delivery
BUNDLE & SAVE
Couldn't load pickup availability
customer checkout trust
HD Labs Tirsema 44mg™
Get it in 5-8 working days
Tirsema 44mg by HD Labs™
Meet the Tirsema 44mg by HD Labs™ — a high dose, precision formulated peptide solution crafted for consistent, reliable results in metabolic and therapeutic research protocols.
About Tirsema
Tirsema, also known as Tirzepatide, is a dual GIP and GLP 1 receptor agonist studied in modern metabolic therapy research. At 44mg per unit, this HD Labs™ formulation offers a potent, research grade format designed for extended treatment cycle research.
44mg High Concentration
Designed for advanced protocols requiring greater potency and extended use.
Dual Agonist Profile
Targets GIP and GLP 1 receptor pathways simultaneously in metabolic research.
HD Labs™ Quality
Produced with a focus on purity, potency and consistency.
Research Grade Formula
Manufactured under strict quality control standards for professional use.
Product Details
HD Labs™ Quality Standard
Crafted for professionals who value consistent formulation, reliable quality and a premium research product experience.
Intended for use by qualified healthcare professionals and researchers. Always consult a licensed medical practitioner before initiating any peptide therapy protocol.
product benefits
Research Grade Quality
Premium peptide products prepared for controlled research and professional use.
Precision Formulation
Carefully measured concentrations designed to support consistency and accuracy.
Secure Product Integrity
Packaged and handled with care to help maintain quality from dispatch to delivery.
Comparison table
Talk about how and why is your brand better than the others.
| EnduroFlow | OTHERS | |
|---|---|---|
Benefit |
||
Benefit |
||
Benefit |
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER
BUILT TO GO FURTHER